|

ASTHMAXcel Voice Study

RECRUITINGN/ASponsored by Montefiore Medical Center
Actively Recruiting
PhaseN/A
SponsorMontefiore Medical Center
Started2025-09-18
Est. completion2028-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* English speaking
* Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
* Able to provide informed consent
* Smartphone access (iOS or Android) with data plan

Exclusion Criteria:

* Pregnancy
* Severe psychiatric or cognitive problems that would prohibit completion of protocol

Conditions1

Asthma

Locations1 site

Montefiore Medical Center
The Bronx, New York, 10467
Sunit Jariwala, MD609-937-1023sjariwal@montefiore.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.